SCROLL
Xeureka Inc. uses the latest computational technology,
including cutting-edge AI and simulations,
to improve the efficiency and success rate of drug discovery research.
Ultimately, we aim to contribute to the swift,
economical delivery of effective medicines to patients suffering from disease.
TECHNOLOGY
In addition to analysis and screening services, we plan to sell software and provide SaaS in the future.
Please contact us to discuss how we can customize a solution to meet your needs, including the establishment of a computing environment.
-
Target Analysis
- AI generation and analysis of multiple putative target structures
- Enhancement of low-resolution structural data
READ MORE
-
Ultra Large Scale Virtual Screening
- Construction of ultra-large scale and AI-generated virtual libraries.
- Virtual Screening approach designed to fit customer needs using SBVS or LBVS.
- Low-cost, large-scale Virtual Screening
READ MORE
-
Free Energy Perturbation（FEP）
- Absolute binding free energy calculation
- High-speed quantum chemical calculations
READ MORE
NEWS / BLOG
-
2025.12 16
NEWS
Xeureka Launches Joint Research Collaboration with the Lokey Laboratory at UC Santa Cruz on the Membrane Permeability of Cyclic PeptidesREAD MORE
-
2025.12 11
NEWS
Xeureka and UBE Announce Joint Research Agreement on Small-Molecule Drug Discovery in the Oncology FieldREAD MORE
-
2025.11 28
NEWS
【Event Report】Sponsored Session at the CBI Annual Meeting 2025: GPU × AI-Powered Drug Discovery R&D — Sharing Knowledge and Growing the Tokyo-1 CommunityREAD MORE